Clinical staff looking for FreseniusRx information for your patients? Click here.

Our Approach

OUR COORDINATED CARE APPROACH

Healthcare in America is complicated, but the FreseniusRx model of care offers opportunities for patient-centric, innovative partnerships.

We believe patients deserve more than just pills in a bottle. Our pharmacy understands the nuances of prescribing patterns for patients with end stage renal disease (ESRD) and the unique requirements of renal specialty medications.

We are able to maximize our value with both patients and clinics through our interdisciplinary, coordinated care team:

Clinical pharmacists focused on renal medications
Nurses with direct patient care and case management experience
Dietitians with experience in serving a variety of patients including dialysis patients
Pharmacy technicians with a focus on comprehensive and compassionate care

We provide an in-depth outreach for our patients and share valuable data with our partners in the Fresenius Kidney Care North America (FMCNA) clinics to work toward improved patient outcomes.

We educate patients on their medications and support adherence to their prescribed therapies.
We work with clinic staff to help improve patients’ prescription refill compliance and make sure their medications are up to date.
We coordinate medication and dosage changes with FMCNA clinic staff and review prescribed medications to ensure they are renal-dosage appropriate.
We ship medications directly to our patients’ clinics*, saving them time and providing an opportunity to review medications and instructions with a knowledgeable healthcare provider.
We provide 24/7 support for our patients with questions about their medications.
We offer personalized services, including side effect monitoring and monthly outreach, helping drive medication adherence to keep patients healthy and out of the hospital.

Reporting & Analytics

OUR APPROACH WORKS

Integrating pharmaceutical services with a patient’s care team may improve medication adherence and decrease hospitalization. While our patients are free to use any pharmacy of their choice, we examined whether patients who utilize the FreseniusRx pharmacy experience improved outcomes more frequently than those who are not taking advantage of this more coordinated medication process.

We conducted a study of more than 57,600 Fresenius Kidney Care North America patients, half of whom were enrolled in FreseniusRx and half of whom received bone and mineral metabolism medications from other pharmacies.

Within 9 months after enrollment, FreseniusRx patients experienced a 9 percent improvement in their target ranges for blood calcium, phosphorus and intact parathyroid hormone goals, compared to patients who were not using FreseniusRx¹.
In addition, study results showed that FreseniusRx patients were up to 11 percent less likely to be hospitalized within their first nine months with FreseniusRx².

Our kidney care pharmacists use technology to drive pharmacy innovation, providing valuable analytics and insights to encourage patient medication management. Our reporting and analytics connect clinical, pharmacy and lab data as part of a coordinated care approach for a complete view of each patient’s overall health and to better manage the patient’s treatment plan.

[1] Rosen S, Larkin J, Thekkumkattil J, Brownlee N, Roberts S, Usvyat L, Hymes J, Ketchersid T, Maddux FW. A renal pharmacy coordinated care program is associated with improvements in bone mineral metabolism outcomes in hemodialysis patients [NKF poster abstract submission #100]. Am J Kidney Dis. 2016.
[2] Roberts S, Rosen S, Thekkumkattil J, Brownlee N, Larkin J, Usvyat L, Hymes J, Ketchersid T, Maddux FW. Associations between a renal pharmacy based coordinated care program and decreased rates of hospitalizations in hemodialysis patients [NKF poster abstract submission #63]. Am J Kidney Dis. 2016.